![Marie-Louise Fjaellskog](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marie-Louise Fjaellskog
Chief Tech/Sci/R&D Officer at
EXSCIENTIA PLC
Net worth: - $ as of 31/05/2026
Profile
Marie-Louise Fjaellskog currently works at Faron Pharmaceuticals Oy, as Non-Executive Director from 2023, Biovica International AB, as Director from 2020, Lytix Biopharma AS, as Independent Non-Executive Director from 2021, the University of Uppsala, as Associate Professor from 2008, and Exscientia Ltd., as Chief Medical Officer & Clinical Development Lead from 2024.
Dr. Fjaellskog also formerly worked at Infinity Pharmaceuticals, Inc., as Vice President-Clinical Development from 2018 to 2019, Merus NV, as Vice President-Clinical Development from 2019 to 2020, and Sensei Biotherapeutics, Inc., as Chief Medical Officer from 2020 to 2021.
Dr. Fjaellskog received her doctorate degree from the University of Uppsala.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/12/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
Marie-Louise Fjaellskog active positions
| Companies | Position | Start |
|---|---|---|
| FARON PHARMACEUTICALS OY | Director/Board Member | 22/09/2023 |
| BIOVICA INTERNATIONAL AB | Director/Board Member | 01/01/2020 |
| LYTIX BIOPHARMA ASA | Director/Board Member | 01/01/2021 |
| EXSCIENTIA PLC | Chief Tech/Sci/R&D Officer | 06/06/2024 |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/12/2008 |
Former positions of Marie-Louise Fjaellskog
| Companies | Position | End |
|---|---|---|
| FAETH THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2021 |
| MERUS N.V. | Chief Tech/Sci/R&D Officer | 01/06/2020 |
| INFINITY PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/04/2019 |
Training of Marie-Louise Fjaellskog
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
63
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Faron Pharmaceuticals Oy
 Faron Pharmaceuticals Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Merus NV
 Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Lytix Biopharma AS
 Lytix Biopharma AS Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops novel cancer immunotherapies | Health Technology |
Biovica International AB
 Biovica International AB BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes blood-based biomarker assays | Health Technology |
Sensei Biotherapeutics, Inc.
 Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
Exscientia Plc
 Exscientia Plc Packaged SoftwareTechnology Services Function as an investment holding company whose subsidiaries provides artificial intelligence and machine learning services | Technology Services |
- Stock Market
- Insiders
- Marie-Louise Fjaellskog
